Published in Nature Communications, the study suggests that it may be possible to regulate the number and activity of these macrophages with drugs that modulate the nuclear receptor RXR
Dr. Sabio leads a research group at the Carlos III National Cardiovascular Research Center (CNIC) whose main line of research are diseases related to obesity, like cardiovascular diseases, diabetes and liver cancer.
Investigadores del Centro Nacional de Investigaciones Cardiovasculares (CNIC) han descubierto por primera vez un mecanismo de protección contra el desarrollo de cáncer asociado a procesos inflamatorios